newheader.jpg
 


Conference Menu

Overview

NEW!
Nanotech Business Perspective Forum

Agenda-Day One
Agenda-Day Two
Download PDF
View 2004 Attendees
Register
Poster
Hotel & Travel
Press Pass
Request Brochure
Send to a Colleague
 

Corporate Support:

 

Sponsoring Organization:

 

Lead Sponsoring Publications:

 Sponsoring Publications:

 

Web Partner:

 

Supporting Association:

 


Held immediately following the
4th Annual Systems Integration in Biodefense, August 24-25, 2005

Overview


The goal of targeted therapeutics is to create drugs that by the specificity of their design and delivery will be more effective in treating disease and less toxic. Nanotechnology offers the possibility of a device and a drug in one, with novel capabilities. It will be necessary to address the challenges that lie ahead: targeted delivery, safety, commercialization and regulatory issues. Nanotechnology promises to create a new class of imaging agents that offer distinct advantages and can be used for the early detection and diagnosis of disease. Diagnostic molecules have the potential to act as biomarkers in drug development and diagnostics, and can be used in the imaging of cancer in living subjects. This meeting will address the challenges in implementing nanotechnology for drug delivery systems and imaging agents, and promote dialogue between diagnostic and therapeutic development.

Extensive Focus on Delivery Strategies
Regulatory and Safety Coverage
Applications in Molecular Imaging
New Partnering Forum for Early Stage Companies
Nanoparticles in the Clinic

Scientific Advisory Board
Dr. Carol A. Dahl, Bill & Melinda Gates Foundation
Dr. Mauro Ferrari, The Ohio State University
Dr. Scott E. McNeil, NCI-Frederick
Dr. Celeste Null, Intel Corporation
Dr. Daniel C. Sullivan, National Cancer Institute
Dr. Stephen McCormack, NeuroSystec Corp.


Sponsors and Exhibitors for the Targeted Nanodelivery for Therapeutics & Molecular Imaging event:
Battelle

Johnson & Johnson


 

For sponsorship information, please contact:
Suzanne Carroll, Manager, Business Development
Phone: 781-972-5452 E-mail: scarroll@healthtech.com


foot.jpg


Cambridge Healthtech Institute| Beyond Genome | Bio-IT World | Biomarker World Congress | Cambridge Health Associates | Discovery On Target |
Health-IT World
| Bio-IT World Conference & Expo  | Molecular Medicine Tri-Conference | PEGS| PepTalk | Pharma DD
World Pharmaceutical Congress |

Your  Life Science Network

Cambridge Healthtech Institute  |  250 First Avenue  |  Suite 300   |   Needham,  MA  02494
Phone: 781-972-5400  |   Fax: 781-972-5425
chi@healthtech.com